Kamata et al., "Mechanism of the Immunosuppressive Action of Bredinin (Mizoribine)," Saishin Igaku, 41(11), 2509-2515 (1986); Chem. Abst., 106(13), p. 3, Abstr. No. 95429r (1987); see original publication with english abstract included. |
Holvey et al. eds., Merck Manual of Diagnosis and Therapy, 12th ed., Merck Research Laboratories, Rahway, N.J., 1972, pp. 1473-1475, particularly pp. 1474-1475. |
Gennaro et al. eds., Remington's Pharmaceutical Sciences, 18th Ed.,Mack Publishing Co., Easton, Pa., 1990, Chapter 61 (Immunoactive Drugs), see pp. 1142-1143. |
Kamata et al., "Mechanism of the Immunosuppressive Action of Bredinin (Mizoribine)," Saishin Igaku, 41(11), 2509-2515 (1986); Chem. Abstr., 106(13), p. 3, Abstr. No. 95429r (1987); only Abstract supplied. |
Kobayashi et al., "Therapeutic Effect of Mizorubine on Spontaneous Autoimmune Disorders in MRL/Mp-Ipr/Ipr Mice," Ensho, 12(2), 193-197 (1992); Chem. Abstr., 117(5), p. 46, Abstr. No. 40028f (1992); only Abstract supplied. |
Berkow et al. eds., Merck Manual of Diagnosis and Therapy, 16th Ed., Merck Research Laboratories, Rahway, N.J., 1992, pp. 2435-2436. |